Bath & Body Works (NYSE:BBWI) Stock Price Down 6% - Here's What Happened

Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) traded down 6% during trading on Friday . The company traded as low as $31.71 and last traded at $32.16. 2,141,152 shares were traded during mid-day trading, a decline of 44% from the average session volume of 3,824,888 shares. The stock had previously closed at $34.20.

Analyst Ratings Changes

BBWI has been the topic of a number of analyst reports. Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $40.00 to $48.00 in a research note on Friday, February 28th. Barclays reduced their price target on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating on the stock in a research report on Monday. Argus restated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Morgan Stanley lowered their price target on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a report on Thursday, November 21st. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average target price of $45.06.

Bath & Body Works Trading Down 4.8 %

The company's 50-day simple moving average is $37.37 and its 200-day simple moving average is $34.18. The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of 7.93, a PEG ratio of 0.92 and a beta of 1.89.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. On average, equities research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.46%. Bath & Body Works's payout ratio is 21.98%.

Bath & Body Works announced that its board has authorized a stock buyback program on Thursday, February 27th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to repurchase up to 6.4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its stock is undervalued.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds have recently bought and sold shares of the company. Golden State Wealth Management LLC bought a new position in shares of Bath & Body Works in the 4th quarter worth about $26,000. SRS Capital Advisors Inc. grew its stake in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after purchasing an additional 329 shares during the period. True Wealth Design LLC increased its holdings in Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock worth $34,000 after purchasing an additional 1,054 shares in the last quarter. UMB Bank n.a. boosted its holdings in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after buying an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC grew its position in shares of Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after buying an additional 431 shares during the period. Institutional investors own 95.14% of the company's stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.